The global market for classical swine fever vaccines is estimated at USD 1.24 billion in 2025 and is projected to increase from USD 1.34 billion in 2026 to approximately USD 2.87 billion by 2035, a 8.3% CAGR from 2026 to 2035.

Market Snapshot

  • Revenue, 2026: 1.34 Billion
  • Forecast, 2035: 2.87 Billion
  • CAGR, 2026-2035: 8.3%
  • Report Coverage: Global

Key Companies

  • Boehringer Ingelheim Animal Health
  • Merial (Zoetis Subsidiary)
  • Ceva Santé Animale
  • Novacor Biotech
  • Agrovet Animal Health
  • CAHIC (China Animal Husbandry Industry Co. Ltd.)
  • Hipra (Laboratorios Hipra S.A.)
  • Intervet-Schering Plough
  • Vacsera
  • Indian Immunologicals Limited
  • Others

About Healthcare Foresights

Healthcare Foresights provides market research and consulting across the healthcare and life sciences industry, combining industry research, analytical expertise and technology-enabled solutions to help companies, investors and decision-makers identify opportunities and drive growth. For the full report, customization or a sample, contact our team.